Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details) - Customer Concentration Risk	3 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Net Revenue | Payer A
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	33.10%	34.00%
Net Revenue | Payer B
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	15.30%	13.50%
Net Revenue | Payer C
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	10.50%
Net Revenue | Payer D
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	10.30%
Net Revenue | Payer E
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	10.10%
Receivables, Net and Receivables-Related Parties and Other Receivables | Payer A
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	44.30%		38.90%
Receivables, Net and Receivables-Related Parties and Other Receivables | Payor F
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	17.60%		16.10%
Receivables, Net and Receivables-Related Parties and Other Receivables | Payer E
Accounts Receivable And Net Revenue [Line Items]
Concentration risk	12.90%		18.30%